1
LetteR tO SHAReHOLDeRS
ISSUe 06 - January 2012
Dear shareholders,
First and foremost I would like to wish you all
a very happy new year. May you all enjoy a
year of good health, profitable investments
and happiness in all your endeavors.
2011 was a year...
More
1
LetteR tO SHAReHOLDeRS
ISSUe 06 - January 2012
Dear shareholders,
First and foremost I would like to wish you all
a very happy new year. May you all enjoy a
year of good health, profitable investments
and happiness in all your endeavors.
2011 was a year of change.
Our board of directors underwent significant
change. As shareholders, you endorsed the
appointment of Mr. Laurent Arthaud (FSI
representative), Mrs. Annick Schwebig and
Mr. Pierre Bastid as members of the board.
On page three of this letter you will find
a detailed outline of Cellectis‘ changes in
governance structure.
In October the Group left its Romainville
premises and relocated to Paris. Since then
we have made our home in Paris‘ 13th
arrondissement at the Biopark, an industrial
hub dedicated to companies working in
biotechnology.
Despite the difficult economic climate
we have managed to achieve a two-fold
restructuring operation in the interest of
our company‘s future: a €50 million capital
increase and the acquisitio
Less